Sixty years of amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections

FB Cavassin, JL Baú-Carneiro, RR Vilas-Boas… - Infectious Diseases and …, 2021 - Springer
Introduced in the late 1950s, polyenes represent the oldest family of antifungal drugs. The
discovery of amphotericin B and its therapeutic uses is considered one of the most important …

Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions

NRH Stone, T Bicanic, R Salim, W Hope - Drugs, 2016 - Springer
Abstract Liposomal amphotericin B (AmBisome®; LAmB) is a unique lipid formulation of
amphotericin B. LAmB is a standard of care for a wide range of medically important …

Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America

PG Pappas, CA Kauffman, DR Andes… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

[HTML][HTML] Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

AJ Ullmann, JM Aguado, S Arikan-Akdagli… - Clinical Microbiology …, 2018 - Elsevier
Abstract The European Society for Clinical Microbiology and Infectious Diseases, the
European Confederation of Medical Mycology and the European Respiratory Society Joint …

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013

OA Cornely, S Arikan‐Akdagli… - Clinical Microbiology …, 2014 - Wiley Online Library
Abstract These European Society for Clinical Microbiology and Infectious Diseases and
European Confederation of Medical Mycology Joint Clinical Guidelines focus on the …

Aspergillosis

BH Segal - New England Journal of Medicine, 2009 - Mass Medical Soc
This review discusses important advances in fungal diagnostics and in the antifungal
armamentarium as applied to aspergillus species. Recent insights concerning host defenses …

Current concepts in antifungal pharmacology

RE Lewis - Mayo Clinic Proceedings, 2011 - Elsevier
The introduction of new antifungal agents (eg, echinocandins, second-generation triazoles)
in the past decade has transformed the management of invasive mycoses to the point that …

[HTML][HTML] ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children

A Warris, T Lehrnbecher, E Roilides… - Clinical Microbiology …, 2019 - Elsevier
Scope Presenting symptoms, distributions and patterns of diseases and vulnerability to
invasive aspergillosis (IA) are similar between children and adults. However, differences …

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children …

WW Hope, E Castagnola, AH Groll… - Clinical Microbiology …, 2012 - Wiley Online Library
Clin Microbiol Infect 2012; 18 (Suppl. 7): 38–52 Abstract Invasive candidiasis (IC) is a
relatively common syndrome in neonates and children and is associated with significant …

Antifungal therapeutic drug monitoring: established and emerging indications

D Andes, A Pascual, O Marchetti - Antimicrobial agents and …, 2009 - Am Soc Microbiol
The successful management of invasive fungal infections continues to pose a difficult
challenge to clinicians. As the population of at-risk immunocompromised patients increases …